MA29730B1 - Detection d'un antigene cible independamment de la presence ou de l'absence d'un anticorps therapeutique correspondant - Google Patents

Detection d'un antigene cible independamment de la presence ou de l'absence d'un anticorps therapeutique correspondant

Info

Publication number
MA29730B1
MA29730B1 MA30617A MA30617A MA29730B1 MA 29730 B1 MA29730 B1 MA 29730B1 MA 30617 A MA30617 A MA 30617A MA 30617 A MA30617 A MA 30617A MA 29730 B1 MA29730 B1 MA 29730B1
Authority
MA
Morocco
Prior art keywords
target antigen
therapeutic antibody
absence
detection
therapeutic
Prior art date
Application number
MA30617A
Other languages
English (en)
French (fr)
Inventor
Helmut Lenz
Werner Scheuer
Martina Thier
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA29730B1 publication Critical patent/MA29730B1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MA30617A 2005-07-06 2008-02-01 Detection d'un antigene cible independamment de la presence ou de l'absence d'un anticorps therapeutique correspondant MA29730B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05014618 2005-07-06
EP06004447 2006-03-06

Publications (1)

Publication Number Publication Date
MA29730B1 true MA29730B1 (fr) 2008-09-01

Family

ID=36922121

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30617A MA29730B1 (fr) 2005-07-06 2008-02-01 Detection d'un antigene cible independamment de la presence ou de l'absence d'un anticorps therapeutique correspondant

Country Status (19)

Country Link
US (1) US20070009976A1 (cg-RX-API-DMAC7.html)
EP (2) EP2194380A3 (cg-RX-API-DMAC7.html)
JP (1) JP2008545145A (cg-RX-API-DMAC7.html)
KR (1) KR20080016939A (cg-RX-API-DMAC7.html)
AR (1) AR053948A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006265275A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0612591A2 (cg-RX-API-DMAC7.html)
CA (1) CA2613187A1 (cg-RX-API-DMAC7.html)
CR (1) CR9635A (cg-RX-API-DMAC7.html)
EC (1) ECSP088081A (cg-RX-API-DMAC7.html)
IL (1) IL188317A0 (cg-RX-API-DMAC7.html)
MA (1) MA29730B1 (cg-RX-API-DMAC7.html)
MX (1) MX2008000277A (cg-RX-API-DMAC7.html)
MY (1) MY157955A (cg-RX-API-DMAC7.html)
NO (1) NO20076662L (cg-RX-API-DMAC7.html)
NZ (1) NZ564471A (cg-RX-API-DMAC7.html)
RU (1) RU2008103608A (cg-RX-API-DMAC7.html)
TW (1) TWI312864B (cg-RX-API-DMAC7.html)
WO (1) WO2007003420A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001264696B2 (en) 2000-05-19 2007-01-04 Genentech, Inc. Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy
ZA200701234B (en) * 2004-07-22 2008-12-31 Genentech Inc HER2 antibody composition
US7936392B2 (en) 2004-10-01 2011-05-03 The Board Of Trustees Of The Leland Stanford Junior University Imaging arrangements and methods therefor
WO2007092545A2 (en) 2006-02-07 2007-08-16 The Board Of Trustees Of The Leland Stanford Junior University Variable imaging arrangements and methods therefor
JO3000B1 (ar) * 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
CA2596133C (en) 2005-02-23 2016-11-15 Genentech, Inc. Extending time to disease progression or survival in cancer patients
PE20070207A1 (es) * 2005-07-22 2007-03-09 Genentech Inc Tratamiento combinado de los tumores que expresan el her
US8358354B2 (en) 2009-01-26 2013-01-22 The Board Of Trustees Of The Leland Stanford Junior University Correction of optical abberations
CA2677108A1 (en) 2007-03-02 2008-09-12 Genentech, Inc. Predicting response to a her inhibitor
TWI472339B (zh) 2008-01-30 2015-02-11 Genentech Inc 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
BRPI0812682A2 (pt) 2008-06-16 2010-06-22 Genentech Inc tratamento de cáncer de mama metastático
PT4403228T (pt) 2011-10-14 2025-10-07 Hoffmann La Roche Utilizações do inibidor da dimerização de her2 pertuzumab e artigo de fabrico que inclui o mesmo
KR101327542B1 (ko) * 2012-03-15 2013-11-08 광주과학기술원 양자점 기반의 경쟁 면역분석법 및 다중 유세포 분석법을 이용한 시료 중 오염물질의 검출 방법
AU2012232949B2 (en) * 2012-09-28 2014-07-03 Willowtree Holdings Pty Ltd Temporary bulkhead
US9815904B2 (en) 2013-04-16 2017-11-14 Genetech, Inc. Pertuzumab variants and evaluation thereof
KR20160141857A (ko) 2014-04-25 2016-12-09 제넨테크, 인크. 트라스투주맙-mcc-dm1 및 퍼투주맙을 이용하는 초기 유방암의 치료방법
PT3302551T (pt) 2015-05-30 2024-08-21 H Hoffnabb La Roche Ag Métodos de tratamento do cancro da mama metastático positivo para her2 não tratado previamente
WO2017087280A1 (en) 2015-11-16 2017-05-26 Genentech, Inc. Methods of treating her2-positive cancer
US20180221481A1 (en) 2016-12-28 2018-08-09 Genentech, Inc. Treatment of advanced her2 expressing cancer
LT3570884T (lt) 2017-01-17 2020-12-10 Genentech, Inc. Poodinės her2 antikūnų kompozicijos
JP6992081B2 (ja) 2017-03-02 2022-02-03 ジェネンテック， インコーポレイテッド Ｈｅｒ２陽性乳癌のアジュバント治療
WO2018200505A1 (en) 2017-04-24 2018-11-01 Genentech, Inc. Erbb2/her2 mutations in the transmbrane or juxtamembrane domain
MX2022015884A (es) 2020-06-29 2023-04-03 Genentech Inc Combinacion de dosis fija de pertuzumab mas trastuzumab.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2095818B (en) 1981-03-27 1985-10-02 Exxon Research Engineering Co Staged adsorption/resorption heat pump
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
CA2103059C (en) * 1991-06-14 2005-03-22 Paul J. Carter Method for making humanized antibodies
WO1993021319A1 (en) 1992-04-08 1993-10-28 Cetus Oncology Corporation HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES
CN101412758A (zh) 1996-10-18 2009-04-22 基因技术股份有限公司 抗ErbB2抗体
JP4424987B2 (ja) 2001-09-20 2010-03-03 ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム Ｅｌｉｓａアッセイを用いた循環する治療抗体、抗原および抗原／抗体複合体の測定
AU2003273218C1 (en) * 2002-07-15 2019-01-17 F. Hoffmann - La Roche Ag Methods for identifying tumors that are responsive to treatment with anti-ErbB2 antibodies

Also Published As

Publication number Publication date
EP1902315A1 (en) 2008-03-26
CA2613187A1 (en) 2007-01-11
AR053948A1 (es) 2007-05-23
MX2008000277A (es) 2008-03-24
KR20080016939A (ko) 2008-02-22
CR9635A (es) 2008-02-20
MY157955A (en) 2016-08-30
NZ564471A (en) 2010-04-30
US20070009976A1 (en) 2007-01-11
ECSP088081A (es) 2008-02-20
NO20076662L (no) 2008-04-03
AU2006265275A1 (en) 2007-01-11
JP2008545145A (ja) 2008-12-11
EP2194380A3 (en) 2010-07-14
BRPI0612591A2 (pt) 2010-11-23
EP2194380A2 (en) 2010-06-09
TW200741203A (en) 2007-11-01
WO2007003420A1 (en) 2007-01-11
IL188317A0 (en) 2008-04-13
RU2008103608A (ru) 2009-08-20
TWI312864B (en) 2009-08-01

Similar Documents

Publication Publication Date Title
MA29730B1 (fr) Detection d'un antigene cible independamment de la presence ou de l'absence d'un anticorps therapeutique correspondant
FR2917174B1 (fr) Analyse multiple d'echantillons sanguins
MX2009009448A (es) Sensibilidad mejorada de determinacion de perfil de anticuerpos a traves de una colocacion en capas incrementada de anticuerpo reportero.
DE60228557D1 (de) Candida-nachweis
DE60219207D1 (de) Diagnostisches testverfahren
DE602005013225D1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
MX2007014815A (es) Metodos de inmunoanalisis mejorados.
NO20083820L (no) Deteksjon av kreft ved forhoyede nivaer av BCL-2
WO2010107654A3 (en) Split flow device for analyses of specific-binding partners
WO2005066612A3 (en) Detection of biomolecules using porous biosensors and raman spectroscopy
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
WO2005041893A3 (en) Detection of acute myocardial infarction biomarkers
WO2007035576A3 (en) Surface plasmon resonance biosensor system for detection of antigens and method for determining the presence of antigens
DK2038430T3 (da) Toll-Like-Receptor-4-dysfunktion og de biologiske anvendelser deraf
NO20052161D0 (no) Analysemetode for hjerte-karsykdom
SG157244A1 (en) Point of care test for the detection of exposure or immunity to dengue virus
WO2005019831A3 (en) Methods for reducing complexity of a sample using small epitope antibodies
SG164389A1 (en) Detection of a therapeutic antibody in an experimental animal
WO2002099381A3 (en) A single-cell biosensor for the measurement of gpcr ligands in a test sample
WO2007024735A3 (en) Method and antibodies for detecting nitrofuran
WO2004084841A3 (en) Novel anti-feline albumin antibodies and methods of detecting early renal disease
Daniso et al. Development of a point of care (POC) test as an immunobiosensor for okadaic acid detection in mussels
WO2007063326A3 (en) Assay device and method
WO2004001371A3 (en) Receptor capture assay
NO20016080D0 (no) Analyse